2025³â 08¿ù 09ÀÏ Åä¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92622°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



Çö´ëÂ÷, Çë°¡¸® ¼ö¿äÀÀ´ä±³Åë ½Ã¹ü»ç¾÷ Âü¿©

¼ÅŬ Ç÷§Æû ±Û·Î¹ú »ç¾÷ È®Àå ±â¹Ý ¸¶·Ã
Çö´ëÂ÷°¡ Çë°¡¸®¿¡¼­ Áö¿ª ±³Åë ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇÑ ¼ö¿äÀÀ´ä±³Åë(Demand Responsive Transport, DRT) ¿î¿µ ½Ã¹ü»ç¾÷¿¡ Âü¿©ÇÑ´Ù. ±¹³» ¼º°øÀûÀÎ ¼ö¿äÀÀ´ä±³Åë ¼­ºñ½º Á¦°ø °æÇèÀ» ¹ÙÅÁÀ¸·Î ±Û·Î¹ú ½ÃÀåÀ¸·Î ¼­ºñ½º È®´ë¸¦ ÃßÁøÇÑ´Ù´Â Á¡¿¡¼­ Àǹ̰¡ ÀÖ´Ù. Çö´ëÀÚµ¿Â÷´Â Áö³­´Þ 31ÀÏ(ÇöÁö½Ã°¢) Çë°¡¸® ±«µÉ·Ú(Gödöllő)½Ã¿¡¼­ ¿­¸° ‘Çë°¡¸® ¼ö¿äÀÀ´ä±³Åë ¼­ºñ½º °³Åë½Ä’¿¡¼­ ÃÖ÷´Ü ¼ö¿äÀÀ´ä±³Åë Ç÷§ÆûÀ» Á¦°øÇϰí, ±Û·Î¹ú »ç¾÷ È®Àå ±â¹ÝÀ» ¸¶·ÃÇÑ´Ù°í 3ÀÏ(ÀÏ) ¹àÇû´Ù. °³Åë½Ä¿¡ µû¶ó 8¿ù 18ÀϺÎÅÍ 10¿ù ...

¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
ÅׯÈ, Ãʰí¼Ó ºí·»´õ ¿ïÆ®¶ó ºí·»µå Ãâ½Ã (2017-06-13)
¾Ë¹Ùõ±¹, ¡®ÀüÀÚ ±Ù·Î°è¾à¼­¡¯ ±¹³» ÃÖÃÊ µµÀÔ (2016-01-04)
¡®°­Ã¶ºÎ´ë3¡¯ 6°³ Ư¼öºÎ´ë, ¸·»ç¿¡¼­ ù ¸¸³² (2023-09-18)
Interactive Brokers Handles Heavy Trading Volume with No Sys... (2024-08-09)
GS25, ÇÏÀý±â °Ü³ÉÇÑ ÀÚ·ç¼Ò¹Ù Ãâ½Ã (2017-08-07)
¹Ì±¹ °£È£»ç ¸éÇã ½ÃÇè ¹× IELTS ¼³¸íȸ (2017-01-16)
Honda Selects BuyCo and FourKites to Digitize and Drive Effi... (2024-06-30)
¼ÒÇü °¡¾Ð ÆßÇÁ ¡®Àª·Î-ÇÏÀÌ¸ÖÆ¼5¡¯ (2016-06-30)
FEELM and Aroma King Continue European Expansion with Trends... (2023-09-21)
°¡Á¤ÀÇ ´Þ ¾ÕµÎ°í ÆÇ¸ÅÆÇÃË ´Ü±â¾Ë¹Ù 107% Áõ°¡ (2017-04-27)
ÇÇÀÚ ¸Ô°í ÄÚÄ«Äݶó ¾Ë·ç¹Ì´½ ÄÅ ¹ÞÀÚ (2016-05-02)
Çϸ² ÇÇ¿ÀºÀ»ç´Ü, ±¤¸íµ¿±¼ üÇèÇнÀ ¹× ¸ñ°¨Ãµ Á¤È­ Ȱµ¿ (2017-06-12)
¼öÁö, ¼±±Û¶ó½º È­º¸ ¡°º½À» ¾´ µí È­»çÇÑ ¹Ì¸ð¡± (2017-02-12)
ĵ½ºÅæ, ºí·çÅõ½º ¹«¼± À̾îÆù LX3 Grigo (2017-06-21)
Experian Publishes Three New Global Reports Focusing on a Ye... (2023-07-12)
¾ÏȣȭÆó ÀÚ¼± ¹× ±âºÎ Ç÷§Æû ¡®µµ³ª¹Ú½º¡¯ ·ÐĪ (2023-09-30)
Çѱ¹¹®È­¿ø¿¬ÇÕȸ ¹®È­Ç°¾ÑÀÌ ¼­Æ÷ÅÍÁî (2023-11-09)
MSCI Appoints Luke Flemmer to Lead and Expand Private Assets... (2024-11-03)
ÀÏ¿ëÁ÷ Àü¿ë ¿ø½ºÅé ÅëÇÕ ÀüÀÚ ³ë¹«°ü¸® ¼­ºñ½º (2022-11-17)
½ÅÈ¥ºÎºÎ ÀÓ´ëÁÖÅà ¡®¹Ý´ë 45.2%¡¯ (2014-11-28)
KBFG Securities America Inc. Selects the Sterling Trading Te... (2024-01-31)
MBN ¡®µ¹½Ì±ÛÁî5¡¯ ¸ñ¿äÀÏ Æí¼º º¯°æ ¡æ È­Á¦¼º »ó½Â¼¼ (2024-05-30)
DGB´ë±¸ÀºÇà ¡®±ºÀ§»ç¶û 5ÀÏÀå µðÁöÅÐÁ¡¡¯ °³Á¡ (2023-11-15)
KB±¹¹ÎÀºÇà, ±¹¹ÎÁö°© °¡ÀÔÀÚ 14°³¿ù¸¸¿¡ 500¸¸¸í µ¹ÆÄ (2023-12-25)
¡®³» ±Í¿¡ ¶ò°î¡¯ Æ÷·¹½ºÅÚ¶ó Á¶¹Î±Ô¸¦ ½Å¼¼°è·Î À̲ö ÀÛ°î°¡´Â? (2024-02-03)
       [ÀÌÀü][1]....[839][840][841][842][843][844][845][846][847]...[3705][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..